BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37839559)

  • 21. NEWLY DIAGNOSED ACTIVE RETINOBLASTOMA IN ADULTS.
    Kaliki S; Shields CL; Gupta A; Mishra DK; Das C; Say EA; Shields JA
    Retina; 2015 Dec; 35(12):2483-8. PubMed ID: 26035399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second primary tumors in retinoblastoma survivors: a study of 7 Asian Indian patients.
    Kaliki S; Palkonda VAR
    Int Ophthalmol; 2020 Dec; 40(12):3303-3308. PubMed ID: 32737729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoreduction for unilateral retinoblastoma.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
    Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on clinical therapeutic effect including symptoms, eye preservation rate, and follow-up of 684 children with retinoblastoma.
    Huang D; Zhang Y; Zhang W; Wang Y; Zhang P; Hong L; Zhou Y; Han T; Zhi T
    Eur J Ophthalmol; 2013; 23(4):532-8. PubMed ID: 23483499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
    Luna-Fineman S; Chantada G; Alejos A; Amador G; Barnoya M; Castellanos ME; Fu L; Fuentes-Alabi S; Girón V; Goenz MA; Maldonado C; Méndez G; Morales RA; Ortiz R; Sanchez G; Wilson M; Rodríguez-Galindo C
    J Clin Oncol; 2019 Nov; 37(31):2875-2882. PubMed ID: 31536438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management and outcome of unilateral retinoblastoma.
    Mallipatna AC; Sutherland JE; Gallie BL; Chan H; Héon E
    J AAPOS; 2009 Dec; 13(6):546-50. PubMed ID: 20006813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global Retinoblastoma Treatment Outcomes: Association with National Income Level.
    Tomar AS; Finger PT; Gallie B; Kivelä TT; Mallipatna A; Zhang C; Zhao J; Wilson MW; Brenna RC; Burges M; Kim J; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català J; Correa-Llano G; Carreras E;
    Ophthalmology; 2021 May; 128(5):740-753. PubMed ID: 33007338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bilateral advanced (group D or E) intraocular retinoblastoma: outcomes in 72 Asian Indian patients.
    Kaliki S; Mittal P; Mohan S; Chattannavar G; Jajapuram SD; Mohamed A; Palkonda VAR
    Eye (Lond); 2019 Aug; 33(8):1297-1304. PubMed ID: 30932036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal versus Postnatal Screening for Familial Retinoblastoma.
    Soliman SE; Dimaras H; Khetan V; Gardiner JA; Chan HS; Héon E; Gallie BL
    Ophthalmology; 2016 Dec; 123(12):2610-2617. PubMed ID: 27712844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective study.
    Radhakrishnan V; Kashyap S; Pushker N; Sharma S; Pathy S; Mohanti BK; Vishnubhatla S; Ghose S; Bakhshi S
    Ophthalmology; 2012 Jul; 119(7):1470-7. PubMed ID: 22463820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
    Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
    Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retrospective review of visual outcome and complications in the treatment of retinoblastoma.
    O'Doherty M; Lanigan B; Breathnach F; O'Meara A; Gallie B; Chan H; O'Keefe M
    Ir Med J; 2005 Jan; 98(1):17-20. PubMed ID: 15782728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. INADVERTENT INTRAOCULAR SURGERY IN CHILDREN WITH UNSUSPECTED RETINOBLASTOMA: A Study of 14 Cases.
    Kaliki S; Taneja S; Palkonda VAR
    Retina; 2019 Sep; 39(9):1794-1801. PubMed ID: 29863537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoblastoma presenting with orbital cellulitis.
    Walinjkar J; Krishnakumar S; Gopal L; Ramesh A; Khetan V
    J AAPOS; 2013 Jun; 17(3):282-6. PubMed ID: 23791410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoblastoma in Jordan, 2003-2013: ocular survival and associated factors.
    Al-Nawaiseh I; Jammal HM; Khader YS; Jaradat I; Barham R
    Ophthalmic Epidemiol; 2014 Dec; 21(6):406-11. PubMed ID: 25317653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China.
    Zhou C; Wen X; Ding Y; Ding J; Jin M; Liu Z; Wang S; Han M; Yuan H; Xiao Y; Wu L; Wang J; Li Y; Yu J; Wen Y; Ye J; Liu R; Chen Z; Xue S; Lu W; Liao H; Cui J; Zhu D; Lu F; Tang S; Wu Y; Yangkyi T; Zhang G; Wubuli M; Guo H; Wang X; He Y; Sheng X; Wang Q; Luo Y; Fan J; Qi J; Yu Z; Tan J; Liang J; Sun X; Jin L; Yang X; Zhang J; Ji X; Zhao J; Jia R; Fan X
    Ophthalmology; 2022 Feb; 129(2):209-219. PubMed ID: 34536465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Globe salvage treatment in group D and group E retinoblastoma.
    Hussain AK; Rahul RA; Carlos RL; Francisco ZM; María GL; Flavia P; Chiara B; Davide B
    Rom J Ophthalmol; 2021; 65(1):20-24. PubMed ID: 33817429
    [No Abstract]   [Full Text] [Related]  

  • 40. Outcomes of Intra- and Extraocular Retinoblastomas from a Single Institute in South India.
    Shah PK; Narendran V; Kalpana N
    Ophthalmic Genet; 2015; 36(3):248-50. PubMed ID: 24372404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.